Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation

Active, not recruitingOBSERVATIONAL
Enrollment

1,020

Participants

Timeline

Start Date

May 14, 2019

Primary Completion Date

May 14, 2029

Study Completion Date

May 31, 2029

Conditions
Malignant Hemopathy
Interventions
OTHER

Blood samples (additional tubes from care) longitudinal

Some sampling times will be systematic, while others will only be performed in the presence of specific post-transplant clinical events (eg relapse, GVH ...).

OTHER

Blood samples (additional tubes from care) at inclusion

"In the case of a transplant from an intrafamily donor (genoid or haploid), we will also collect blood samples from the donor. A single blood sample of 28 mL (7 EDTA tubes) will be made.~In order not to represent an additional sample for the donor, this sample will be taken before the mobilization of the hematopoietic stem cells, during the biological assessment required for the biological donation qualification."

Trial Locations (1)

13009

Institut Paoli-Calmettes, Marseille

All Listed Sponsors
collaborator

INSERM-U1068

UNKNOWN

lead

Institut Paoli-Calmettes

OTHER

NCT03965429 - Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter